Abstract
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3, by J. Wang, J. Guo, H. Fan, published in Eur Rev Med Pharmacol Sci 2019; 23 (12): 5168-5175-DOI: 10.26355/eurrev_201906_18181-PMID: 31298410" has been withdrawn. The authors stated that the problem was related to "substantial deficiency in the experimental design (Figures 3B and 4C, 4E, and 4F). The experiment was not done well at that time. It was processed by computer and there were some inaccuracies". The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/18181.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European review for medical and pharmacological sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
